Investor Relations – Merchavia

Overview

Company Profile

Presentation

Company Presentation

Reports

Immediate Reports

Financial

Financial Reports

Investors News

Financial Reports

Management

Management

Stock

Stock Chart

FAQ

FAQ

Alert

Mail Alert

Contact

Contact IR

Stock Quote

Tel Aviv: MRHL

37.5

Price

0%

Change percentage

0

Change

0

0

Last Update:24/11/2022

at:00:00

Presentations

Financial Reports

Immediate Reports

Results of General Meeting held on Nov 8, 2022

08/11/2022

CD’X (about 5.5%) received approval from an American health insurer to cover the use of IsoPSA for the early diagnosis of prostate cancer

11/10/2022

Calling of Annual Meeting for Nov 8, 2022

03/10/2022

Nerview (7.63%) will invest 300 A$ in Medipress against an allocation of about 3.27% in Medipress

27/07/2022

Read more

Investors News

CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

10/02/2021

Globes: 32 million distribution agreement for Cardiacsens from Merchavia Group

08/06/2020

Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India

08/06/2020

Yahoo Finance: Israeli tech firm to sell $32.4 million in medical watches in India

07/06/2020

Read more

News in the Media

OCON’s Pioneering IUB™ Ballerine® Femtech Applauded by Frost & Sullivan

23/04/2021

MERCHAVIA Holding and Investments Announces the nomination of Dr. Eran Schenker as Medical Director

04/01/2021

Innovative Israeli Medical Devices in the UAE: The Cardiacsense Medical Watch for Identifying Arrythmia Will be Sold in the UAE

15/09/2020

A Significant Vote of Confidence in Merchavia Holdings and Investments Ltd: More Investment House will lead a 4 million-shekel round of investment

14/09/2020

Read more

Mail Alert

Subscribe to Receive Notifications by Email:

Stock Price

Tel Aviv: MRHL

37.5

Price

0%

Change percentage

0

Change

0

0

Last Update:24/11/2022

at:00:00